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Abstract.  Qualitative and quantitative changes in neu- 
ral cell adhesion molecule (N-CAM) protein and 
mRNA forms were measured during myogenesis in 
G8-1 and C2 cell lines.  Indirect immunofluorescence 
assay showed that N-CAM was constitutively expressed 
by myoblasts in culture and that myotubes appeared to 
be stained more strongly.  These changes were quanti- 
fied using a dot blot assay.  N-CAM levels increased 
almost 4-fold in G8-1  cells and  15-fold in C2 cells 
during myogenesis. The kinetics of accumulation of 
N-CAM were not coordinate with other muscle mark- 
ers such as creatine kinase or acetylcholine receptor 
levels, since N-CAM accumulated significantly ahead 
of these markers.  Immunoblotting showed that myo- 
genesis was not associated with changes in the extent 
of sialylation of N-CAM.  However, distinct changes in 
desialo forms were observed after neuraminidase  treat- 
ment.  Myogenesis was accompanied by increases in 
125- and  155-kD  desialo forms with minor changes in 
120- and  145-kD forms. Biosynthetic labeling studies 
showed that myoblasts specifically expressed a trans- 
membrane isoform of 145 kD that was phosphorylated 
and was down-regulated in myotubes. Pulse-chase 
analysis of myotubes showed that the 120-kD isoform 
and an isoform of 145 kD that co-migrated with, but 
was distinct from, the 145 kD transmembrane isoform 
of myoblasts were precursors of the 125- and  155-kD 
isoforms, respectively, that accumulated in myotubes. 
The  125- and  155-kD  isoforms in myotubes are linked 
to the cell membrane via phosphatidylinositol linkage 
and can be released by phospholipase C.  Indirect im- 
munofluorescence analysis showed that phosphatidyl- 
inositol specific phospholipase C  specifically released 
N-CAM from the myotube membrane generating 
N-CAM-free myotubes, while myoblasts were unaf- 
fected by this  treatment.  Three N-CAM mRNA species 
were observed in mouse muscle cell lines.  Myoblasts 
were characterized by their expression of 6.7- and 
5.2-kb transcripts  while myotubes express 5.2- and 
2.9-kb transcripts.  Thus,  myogenesis is qualitatively 
associated with a down regulation of the 6.7-kb tran- 
script and an up regulation of the 5.2- and 2.9-kb 
transcript. 
N 
'EURAL cell adhesion molecule (N-CAM) ~  is the best 
characterized  cell adhesion molecule and is likely to 
be of crucial importance in regulating  cell-cell in- 
teractions  in the brain and other tissues  (11, 34).  It is well 
placed to play a pivotal  role in such systems because it is 
expressed in a variety of alternatively  spliced (10, 29) molec- 
ular forms of different sizes that can be differentially  glyco- 
sylated (11, 12, 34) and because subpopulations of the mole- 
cule  may  express  unique  antigenic  determinants  (31).  A 
number of studies have been reported on the in vitro and in 
vivo expression of N-CAM in skeletal muscle (6-9,  17, 26, 
27, 30, 32, 33, 38, 43, 44, 46) and a number of roles have 
been proposed for N-CAM in this tissue. These include myo- 
blast fusion (8, 39), the interaction of nerve and muscle dur- 
ing in vitro and in vivo neuromuscular synaptogenesis  (33), 
and the interaction of primary and secondary myoblasts dur- 
1.  Abbreviations used in  this paper:  AchR, acetylcholine receptor;  CK, 
creatine kinase; GPDH, glyceraldeh),de  3-phosphate dehydrogenase; N-CAM, 
neural cell adhesion molecule; T4, thyroxine. 
ing histogenesis  (20, 21). However, it will be necessary to 
have a full molecular profile of N-CAM expression and regu- 
lation in skeletal muscle before it will be possible to address 
precisely the question of whether or not this molecule is in- 
volved in specific muscle functions. As most of the assay sys- 
tems available for study of N-CAM function use cells in cul- 
ture, it is necessary in the first instance to have a clear picture 
of N-CAM expression in appropriate  in  vitro models.  A 
number of skeletal muscle cell culture systems have indeed 
been analyzed in this respect. These include primary cul- 
tures of human (26, 44), rat (7, 8), and chicken muscle (17), 
and several rodent cell lines (7, 46). In human muscle cell 
cultures N-CAM has been shown to be expressed by cycling 
myoblasts (26) but in neonatal rat cultures N-CAM has been 
shown to be present on myosin-positive  myocytes and an- 
other uncharacterized  population, probably myoblasts  (7). 
Differing  results  have been found with respect to N-CAM 
molecular forms in  muscle, probably due to the different 
types of analyses  carried out. Immunoprecipitation  of bio- 
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muscle yielded a single polypeptide of 135 kD 00) while 
Western blotting of NP-40--extractable proteins from sh-ailar 
cells showed a greater degree of polydispersity (7). Cell sur- 
face lactoperoxidase labeling ofrat L6 cells identified the fol- 
lowing after immunoprecipitation:  N-CAM polypeptides of 
140 and 120 kD, and small amounts of a 180-kD component 
(46). 
There are still,  however, a number of unanswered  ques- 
tions concerning  the precise mode of expression of N-CAM 
in  skeletal  muscle.  We have attempted  to answer  some of 
these using mouse muscle cell lines G8-1 and C2. In particu- 
lar,  we have attempted  to address the following questions. 
When does N-CAM appear on myoblasts and are there any 
changes in N-CAM levels during in vitro myogenesis? Is it 
possible to modulate N-CAM levels in culture? What are the 
changes in N-CAM isoforms during myogenesis, and are the 
different bands found on Western blots the products of the 
same or different mRNAs? What is the temporal  pattern of 
change of N-cAM-specific mRNA species and how do they 
change quantitatively  and relate to other markers of muscle 
differentiation? 
Materials and Methods 
Cell Cultures 
The mouse muscle cell lines (]8-1 (5) and C2 (4, 36, 47) were obtained from 
Dr. M. Nirenberg, National Heart, Lung, and Blood Institute, Bethesda, 
MD, and Dr.  H.  Blau,  Stanford University, Stanford, CA, respectively. 
They were grown on collagen-coated (Vitrngen; Collagen Corp., Palo Alto, 
CA) culture dishes in DME containing 10% FCS for G8-1 cells and 20% 
FCS and 0.5 % chick embryo extract for C2 cells. To induce myotube forma- 
tion in GS-1 cells the above media was changed to DME containing 5 % 
horse serum and 0.5 % FCS while C2 cells were treated with DME contain- 
ing 2% horse serum. In some experiments, fused cultures of  G8-1 cells were 
treated with tetrodotoxin or thyroxine (1"4). Tetrodotoxin (0.5 $tg/ml) or T4 
(0.89 I~g/ml) was added for 4 d, after which cells were analyzed for N-CAM 
levels. 
Antibodies, Indirect Immunofluorescence, 
and Immunoblotting 
Two anti-N-CAM antibodies were used in the present study.  These were 
the anti-N-CAM mAb H28 (15) and rabbit anti-mouse muscle N-CAM an- 
tisera. The latter reagent was produced as follows. Mouse G8-1 cells were 
grown to confluence and extracted with 1% NP-40 in Tris-buffered saline 
(TBS),  pH  7.4,  containing trasylol  (2  Utml) and  phenylmethylsulfonyl 
fluoride (PMSF) (1 raM). The extract was spun at 100,000 g for 1 h at 4~ 
and the soluble fraction frozen at -20~  until use. The thawed extract was 
applied first to a  nonspecific column containing rabbit immunoglobulin 
bound to Sepharose 4B and the unretarded extract was applied to a second 
column containing H28 mAb bound to Sepharose 4B. After extensive wash- 
ing, bound N-CAM was elnted from the H28 mAb column with 0.05  M 
diethylamine, 1% NP-40 (pH 11.5) and neutralized with solid glycine. Rab- 
bits were injected with purified N-CAM (50 gg/injection) on four occasions 
over 8 wk to induce a strong immune response. The third bleed was used 
in the presem experiments and had a  titre of 1:6,000 in an ELISA using 
mouse brain homogenate bound for 2 h to microtitre plates. 
Indirect immunofluorescence  staining was carried out as described previ- 
ously (42). A  1:100 dilution of H28 mAb ascites fluid was used for these 
experiments and,  as detecting antibody, a  t:100  dilution of fluorescein- 
labeled anti-rat immunoglobulin was used. The polyclonal rabbit anti-N- 
CAM was used at a  1:100 dilution and the detecting antibody was sheep 
anti-rabbit labeled with fluorescein. 
Immunoblotting was  carried  out as described previously with some 
modifications (26). 50 I~g of NP-40-extracted cellular protein was added per 
gel track and after electrophoresis and transfer to nitrocellulose, nonspecific 
binding sites were blocked with PBS containing 2 % casein (pH 7.2).  Anti- 
bodies used were either H28 mAb or rabbit ami-N-CAM. The detecting 
antibodies were rabbit anti-rat peroxidase for H28 mAb and sheep anti- 
rabbit peroxidase for rabbit anti-N-CAM. These were visualized with color 
development reagent (HRP; Bio-Rad Laboratories, Richmond, CA) in the 
presence of 0.02% H202. 
Neuraminidase was used to generate desialo N-CAM. Neumminidase 
(type X, final concentration 0.5 U/ml; Sigma Chemical Co., St. Louis, MO) 
was added to NP-40 extracts from muscle cell cultures (1 mg/ml protein) 
in 2.5 mM sodium acetate buffer, pH 5.0, for 1 h. At the end oftbe reaction 
time samples were treated as for immunoblotting. 
Biosynthesis of N-CAM and Effect of Tunicamycin 
and Phospholipase C 
Muscle cells at myoblast or myotube stages were labeled with either L- 
[3SS]methionine  or [32p]inorganic  phosphate. Cells were washed twice in 
PBS and methionine  or phosphorus-free  DME followed  by either 50 ttCi/ml 
L-[35S]methionine  or  500  I.tCi/ml  [32Plinor~c phosphate (Amersham 
International, Amersham, United Kingdom). Cultures were routinely in- 
cubated for 4 h and the cells washed three times in PBS and harvested as 
described for immunoprecipitation analyses. For pulse-chase studies, ceils 
were treated as above, with chase incubations in DME containing 10% FCS. 
When radiolabeling was done in the presence of tunicamycin, the drug 
(5 gg/ml) was added 30 rain before radiolabeling and fresh drug was in- 
cluded in the labeling media. 
Phospholipase C release of N-CAM was carried out on cultures labeled 
for 4 h with L-[35S]methionine and after three washes in PBS the labeled 
cells were incubated in DME containing 10 U/ml (12 U/mg) phospholipase 
C  (JR  cereus,  type KI; Sigma Chemical Co.) for 1 h at 3"7~  The media 
was then collected, filtered through a 0.22-ttm filter, and N-CAM immuno- 
precipitated as below. 
Phosphatidylinositol-specific  phospholipase C from Bacillus thuringien- 
sis (a gift from Dr. M. Low) was used to assess which cells in culture ex- 
pressed N-CAM isoforms that were sensitive to the action of this enzyme. 
C2 myotubes were grown on coverslips and phosphatidylinositol-specific 
phospholipase C added at a level of 12 U/m1 in PBS for 45 rain at 37~ 
Samples were then processed for immunofluorescence analysis of N-CAM 
as described above. 
Immunoprecipitation of N-CAM Polypeptides 
Muscle cells labeled as above were washed three times in PBS and harvested 
into ice-cold extraction buffer containing 10 mM Tris-HCi, pH 7.4,  1% NP- 
40, 2.5 mM EDTA,  1 mM PMSF, and 2 U/mi aprotinin (buffer A). The 
cell lysate was left on ice for 20 rain and then centrifuged for 10 min at 10,000 
rpm. The supernatants (0.5 ml) or media were then cleared with 50 tll of 
a 10 % solution of  preimmune rabbit Ig-coated Staphylococcus  aureus bacte- 
ria for 30 min at 4~  The supernatants were cleared by centrifugation and 
20% vol/vol of 2% casein in 5 M NaC1 was then added followed by 2  Itl 
of  rabbit anti-N-CAM antisera. The supernatants were left at 4~  overnight 
and then centrifuged for 10 rain before being transferr~ to a new centrifuge 
tube. To this was added 50 gl of  a 10 % suspension of Staphylococcus  aureus 
cells.  After 60 min at 4~  with occasional mixing the suspension was 
washed six times in 0.5 nil buffer A containing 0.5 M NaCI and twice more 
with buffer A without NP-40 but with 0.1% SDS. The resulting pellets were 
then either suspended in 25 mM acetate buffer, pH 5.0, for neuraminidase 
treatment, or boiled in SDS sample buffer for polyacrylamide gel elec- 
trophoresis analysis. 
Creatine Kinase Assay and a-Bungarotoxin Binding 
Two well characterized biochemical markers were used to follow the ki- 
netics of fusion in G8-1 and C2 cultures, namely creafinc kinase (CK) levels 
(39) and acetylcholine receptor (AchR) levels as assessed by a-bungarotoxin 
binding (14). For CK assay, samples were harvested at specific time points 
into PBS, sonicated for 15 s, and their enzyme levels measured with the UV 
kit (Bcmhringer Mannheim, Law~, United Kingdom). Protein levels were 
measured by the Lowry protein assay using BSA as standard. For assess- 
ment of r  binding, samples were harvested as above into PBS 
containing 1% BSA. Binding of ~2sI-a-bungamtoxin (Amersham Interna- 
tional) was determined in suspension, and otherwise according to Franklin 
et al. (14), and the specific binding found by adding an excess of unlabeled 
ct-bungarotoxin (Sigma Chemical Co.). 
Quantitation of N-CAM Levels 
N-CAM levels were quantitated using a dot blot ELISA. Serially diluted ali- 
quots (50 gl) of G8-1 and C2 cell homngenates of  known protein concentra- 
The Journal  of Cell Biology,  Volume 105,  1987  1378 tions were spotted onto nitrocellulose (0.45 I~m, Schleicher & Schuell, Inc., 
Keene,  NH) using a Bin Dot apparatus (Bio-Rad Laboratories). The filter 
was  then transferred to PBS containing 2 % casein for 30 rain to block 
nonspecific binding sites. A 1:1,000  dilution of H28 mAb in PBS, 2% casein 
was added for 1 h at 20"C.  The filter was washed and a 1:1,000 dilution of 
peroxidase-conjngated  rabbit anti-rat Ig added for 1 h at 20~  The filter 
was washed extensively and finally treated with an aliquot of HRP color de- 
velopment reagent in the presence of 0.02% H202. Dots were scanned with 
a Chromoscan 3 apparatus (Joyce, Loebl and Co. Ltd., Gateshead, England) 
and the relative level of N-CAM protein calculated  from the linear region 
of the graph of protein concentration versus signal intensity. 
Isolation of mRNA 
RNA was extracted from cells at various time points after plating by extract- 
ing cells overnight at 40C in 3 M LiCl, 6 M urea, 0.5% wt/vol SDS, 0.1% 
wt/vol  hepafin, 0.1  M sodium acetate,  pH 5.2  (1). Samples  were  spun at 
10,000 g for 30 rain, resuspended in 3 M LiCl and 6 M urea, and recen- 
trifuged.  The precipitated  pellet was  resuspended in 0.2%  wt/vol  SDS, 
0.1 M sodium acetate, pH 5.2, extracted twice with phenol/chloroform  (1:1), 
once with chloroform, precipitated with ethanol, and resuspended in 10 mM 
Tris,  0.5 M  EDTA. 
Poly(A) § RNA was isolated by one round of affinity chromatography  on 
oligo dT-cellulose  (Sigma Chemical Co.) (2) and resuspended in 1-120. 
Northern Blot Analysis of  RNA 
Samples of Poly(A) + RNA were denatured with glyoxal (37), separated  by 
electrophoresis on 1% agarose gels, and transferred to a membrane (Gene- 
screen;  New  England Nuclear,  Boston, MA)  in  15 mM  NaH2PO4 (pH 
6.5). 
Filters were submerged in 10 mM Tris HCI (pH 8) at 100~  for 30 min 
and then prehybridized for 18 h at 42~  in 50% formamide,  0.04% poly- 
vinylpyrollidone,  0.04% BSA, 0.04% FicoU, 5x saline sodium citrate (Ix 
SSC: 0.15 M NaC1, 0.015 M sodium citrate),  1% SDS,  100 Bg/mi sheared, 
denatured calf thymus DNA (Sigma Chemical Co.) and 2 ~tg/ml Poly A and 
1 ~tg/ml Poly G (Sigma  Chemical Co.).  Hybridization was carded out in 
the same solution at 42~  for 18 h with 3.9  x  106 cpm/ml of electropho- 
retically  purified insert from the N-CAM cDNA probe pMI.3 (16) labeled 
by nick translation (16). 
Filters were washed with 2￿  SSC, 0.1% SDS twice for 15 rain at 20~ 
followed by washes at 0.2x SSC, 0.1% SDS twice for 30 min at 65~  For 
automdiogmphic analysis filters were exposed to Fuji x-my film at -70~ 
in the presence of an intensifying  screen. 
In some experiments the level of N-CAM hybridizing bands was com- 
pared with a control probe whose level did not change during myogenesis. 
For these experiments we used cDNA probe to glyceraldehyde-3-phosphate 
dehydrogenase  (GPDH) (24).  Blots were treated as follows. The N-CAM 
probe pM1.3 was removed by washing for 1 h at 65~  in 5 mM Tris-HCl 
(pH 8), 0.2 mM Na2 EDTA, 0.05%  sodium pyrophosphate,  0.002% poly- 
vinylpyrollidone,  0.002 % BSA, and 0.002 % Ficoll, and then prehybridized 
and hybridized as above in 50% formamide,  0.04% polyvinylpyrollidone, 
0.04% BSA, 0.04% Ficoll, 5x SSC, 1% SDS, 100 gg/ml sheared denatured 
calf thymus DNA, and 1 Bg/mi Poly A/Poly G with 3.5  x  106 cpm/ml of 
cDNA probe to chicken GPDH (24), labeled by nick translation. 
Filters were washed in 2 x  SSC, 0.1% SDS twice for 15 min each at 20~ 
and then twice for 30 min at 65~  and autoradiographed  as before. 
Densitometric analysis of autoradiographs  was carried out on a Chro- 
moscan 3 apparatus. 
Results 
Qualitative and Quantitative Changes in 
N-CAM Levels during Myogenesis in Culture 
The mouse muscle cell lines G8-1 and C2 were chosen to 
analyze the expression of N-CAM during myogenesis. These 
cell lines form myotubes reproducibly and with high fre- 
quency (4, 5). In addition, G8-1 cells will synapse with ap- 
propriate neural cell lines (5) and we have shown specific 
changes in cell surface proteins during myogenesis (41). G8-1 
and C2 cells were grown in cell culture for varying periods 
of time and allowed to go through their myogenic program. 
Figure 1. Expression of N-CAM in cell cultures of mouse G8-1 ceils 
during myogenesis. Indirect immunofluorescence was used to show 
the distribution of N-CAM after different periods of time in culture. 
(a, c,  e, and g) Phase-contrast views of cells;  (b, d, f, and h) the 
same cells stained with anti-N-CAM. Samples were examined after 
different times of culture. These were (a) 1 d, (c) 3 d, (e) 6 d, and 
(h)  10 d.  Bar,  100  tim. 
Fig. 1, a, c, e, and g shows the morphological development 
of G8-1 cells after various periods of time in culture and Fig. 
1, b, d, f, and h  shows the same cells stained with anti-N- 
CAM.  These cells start as mononucleate cells that divide 
rapidly and after alignment begin fusing to form myotubes 
after 5 d in culture. Fusion continues beyond this time and 
by day 10 the myotubes increase in size and start contracting. 
Like all other rodent muscle cell lines previously analyzed, 
such as C2 cells, BC3H1 cells (7), L6 cells (46),  and 101"% 
clones (Moore, S. E., and E  S. Walsh, unpublished observa- 
tions), the G8-1 cells expressed N-CAM.  This was shown 
by immunofluorescence using the mouse N-CAM-specific 
mAb H28  that reacts with a  backbone polypeptide deter- 
minant of mouse N-CAM (15). No reactivity with the cells 
was observed when mAb H28 was omitted from the staining 
reaction or a control mAb was substituted for mAb H28. In 
addition, similar staining patterns were found with the poly- 
clonal rabbit anti-N-CAM antibody. Indirect immunofluo- 
rescence analysis of N-CAM expression during myogenesis 
in G8-1 cultures revealed the following. At the earliest time 
point (24 h) after plating, when all cells in the culture are 
mononucleate, all cells were positive for N-CAM (Fig.  1, a 
and b). This shows that N-CAM is constitutively expressed 
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have to commit to become myocytes before N-CAM is ex- 
pressed. This expression of N-CAM remained stable at the 
next time point immediately before the onset of fusion (Fig. 1, 
c and d) and it was not until the third time point, when fusion 
was starting to occur, that qualitative changes in N-CAM 
staining intensity  became apparent (Fig. 1, e and  f). As soon 
as small myotubes began to appear in the G8-1 cultures they 
could be clearly identified from background myoblasts on 
the basis of a much enhanced fluorescence staining intensity. 
Thus, myotubes appeared to express more N-CAM per unit 
area than myoblasts. This distinction became more pronounced 
as the myotubes became larger and more differentiated (Fig. 1, 
g and h). The immunostaining was distributed over the entire 
myotube's surface with no observable areas of specialization 
or local concentration. The residual myoblasts in the differ- 
entiated cultures still expressed N-CAM but less than myo- 
tubes. These results show that in this model system all mus- 
cle cells express N-CAM at the cell surface but that myotubes 
exhibit an apparent enhanced expression. This profile of ex- 
pression of N-CAM in G8-1 cells was not peculiar to these 
cells, as we found similar results with C2 cells (data not 
shown). 
To further characterize the apparent differences in N-CAM 
levels between myoblasts and myotubes a  quantitative dot 
blot ELISA assay for N-CAM was developed to measure the 
binding  of mAb  H28  to  G8-1 cell  extracts  adsorbed  to 
nitrocellulose. In addition, at each time point in culture, two 
independent indices of  myogenesis  were studied, namely CK 
activity and AchR levels. These parameters serve as internal 
indices for fusion and myotube formation in the cell cultures, 
as it has been found that with fusion both CK and AchR 
levels rise in muscle cultures in parallel (25).  Graphs of 
N-CAM immunoreactivity versus protein concentration in 
G8-1 and C2 ceils at different times of culture were drawn 
to determine the linear region of the curve (not shown). 
N-CAM relative abundance was calculated and an attempt 
was then made to correlate the increase in N-CAM in these 
cultures with CK and AchR levels. Fig. 2 shows a compari- 
son of N-CAM levels with those of CK and AchR in G8-1 
and C2 cells during differentiation. CK and AchR levels are 
low in G8-1 and C2 myoblasts, but,  as shown previously 
(25), concomitant with the appearance of myotubes the level 
of these markers increases in parallel and continues to do so 
at each of the further time points analyzed. N-CAM levels 
do not increase with the same kinetics as CK and AchR. Fig. 
2 a  shows the rise in N-CAM levels in G8-1 and Fig. 2 b 
shows the levels in C2 cells. Both these cell lines, which fuse 
with different kinetics, behave in the same way. N-CAM lev- 
els are low but above background levels at the first time 
point. The N-CAM levels rise rapidly with time in culture 
and the main phase of increase precedes CK and AchR in- 
creases. This was found for both G8-1 and C2 cells. Thus, 
the rise in N-CAM levels is not linked to the coordinate acti- 
vation of CK and AchR. 
N-CAM shares some properties with the AchR in muscle 
with respect to its pattern of expression and location in mus- 
cle in vivo and in its response to denervation and paralysis 
(6, 26, 27, 32). One feature of the expression of the AchR in 
vitro is that it can be regulated by membrane activity (22) 
and hormones (35). We therefore wished to determine wheth- 
er these factors could influence N-CAM levels. We grew G8- 
1 and C2 cells for 4 d in 0.5 lxg/ml tetrodotoxin to alter mus- 
cle membrane activity or hormone treated with 0.89 pg/ml 
T4.  In three independent experiments we were unable to 
show any statistically significant change in N-CAM levels 
with the tetrodotoxin or T4 treatment, suggesting that in ad- 
dition to showing different  kinetics of  accumulation to AchR, 
N-CAM does not appear to be modulated by some factors 
that regulate AchR. 
N-CAM Isoform Changes during Myogenesis 
Immunoblotting was used to analyze the changes in N-CAM 
protein forms during myogenesis. Fig. 3, a and b shows the 
result of  immunostaining of  cell extracts of  G8-1 and C2 cells 
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Figure 2. Comparison of  the kinetics of accumulation of  N-CAM in cultures of G8-1 (a) and C2 (b) ceils with CK and AchR. Graph shows 
the rate of N-CAM (solid circles), CK (open circles), or AchR (squares) accumulation with time of culture. 
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(a) and C2 (b) cells. Three time points were chosen for each cell 
line, namely prefusion (lanes 1 and 4), midfusion (lanes 2 and 5), 
and postfusion (lanes 3 and 6). Samples were harvested from cul- 
ture dishes and extracted with NP-40 and 50 Ixg of untreated (lanes 
1-3) or neuraminidase-treated sample (lanes 4-6) added to the gel. 
After electrophoresis protein was transferred to nitrocellulose and 
reacted with anti-N-CAM.  Molecular mass markers are shown to 
the right of each blot and are given in kilodaltons. 
during myogenesis. 50 lxg of NP-40-extracted cellular pro- 
tein from each time point was added per gel track and stained 
with rabbit anti-N-CAM. As in previous studies there were 
low levels of N-CAM in myoblasts (Fig. 3, a and b, lanes 1 ), 
but  a  faint  band  of  ~110  kD  could  be  seen.  As  time 
progressed the amount of  this band increased, as did a diffuse 
band extending up to ,,0220 kD.  As previously shown (7), 
there was no observable shift in the spread of this band with 
time in culture. Neuraminidase treatment was used to gener- 
ate desialo N-CAM that can be resolved into discrete bands 
on polyacrylamide gels. Fig. 3, a and b, lanes 4-6, shows the 
results for G8-1 and C2 cells. For C2 cells these data can be 
compared with those reported previously (see Fig. 3, lanes 
11 and 12 in reference 7). Fig. 3 b, lane 6, shows four protein 
bands  of 120, 125, 145, and  155 kD present in a  ratio of 
1:9:2:2. On long exposures a minor band of 180-190 kD was 
sometimes found in cultures, but the significance of this is 
not clear at present. The major band of 125 kD corresponds 
to the previously described 125-kD band and the band of 145 
kD corresponds to the previously described 140-kD band (7). 
A  similar banding pattern was  found in cultures on G8-1 
myotubes (Fig.  3 a, lane 6). The first myoblast time point 
mainly shows the 145-kD band in both G8-I and C2 cells 
(Fig.  3, a  and b,  lane 4) with small amounts of a  120-kD 
band. The levels of these two bands do not change apprecia- 
bly in culture.  However, there is a  characteristic increase 
during myogenesis in the 125- and 155-kD bands during the 
second (Fig. 3, a  and b, lane 5) and third (Fig. 3, a  and b, 
lane 6) time points. Thus, myogenesis in G8-1 and C2 ceils 
is accompanied by the appearance of 125- and 155-kD bands. 
Little change was found in the level of the 145- and 120-kD 
bands.  Similar results were found if we used mAb H28 to 
study N-CAM protein forms. 
Biosynthesis and Posttranslational Modifications 
of  N-CAM in G8-1 Cells 
The immunoblot study was unable to resolve the question of 
the  relationship  between the  four desialo  N-CAM  bands 
shown above. To further address this question we analyzed 
aspects of N-CAM biosynthesis and processing. First, G8-1 
cells at myoblast and myotuhe stages of growth were meta- 
bolically labeled with [35S]methionine and afterwards N-CAM 
polypeptides immunoisolated from NP-40-extracted cells. 
Fig. 4 (lanes I  and 2) shows the N-CAM polypeptides found 
in immunoprecipitates of G8-1 myoblasts and myotubes after 
neuraminidase treatment. The profile observed is very simi- 
lar to that found on the Western blots. Confluent myoblasts 
predominantly express a band of 145 kD with an additional 
less intense band at  120 kD.  Myotubes also express these 
bands, and, in addition, bands at 125 and 115 kD. A phos- 
phorylation study was carried out to further analyze the rela- 
tionship between isoforms. Neuronal N-CAM polypeptides 
of 180 and 140 kD but not of 120 kD have been shown to be 
phosphorylated (12, 23, 34). We therefore metabolically la- 
beled  myoblasts  and  myotubes with  [32p]inorganic  phos- 
phate in the presence or absence of  tunicamycin and then im- 
munoisolated N-CAM polypeptides. Fig. 5  (lane 1) shows 
that the major N-CAM isoform of 145 kD found in myoblasts 
incorporates [32p]inorganic  phosphate while the additional 
minor bands do not.  This result suggests that the  145-kD 
N-CAM isoform is a transmembrane protein, as [32p]inor- 
ganic phosphate is believed to be added to the cytoplasmic 
domains of membrane proteins (12). The 145-kD phosphor- 
Figure 4.  Biosynthetic labeling of N- 
CAM  in  G8-1 myoblasts and  myo- 
tubes.  GS-1 myoblasts or  myotubes 
were metabolically labeled with pS]- 
methionine, the cells solubilized with 
NP-40,  and  N-CAM-reactive  poly- 
peptides isolated. Samples were then 
treated with neuraminidase and sepa- 
rated on polyacrylamide gels. Lanes 1 
and  2  show [35S]methionine-labeled 
immunoprecipitates  from (lane 1) myo- 
blasts and (lane 2) myotubes. Molecu- 
lar mass  markers  are given in kilo- 
daltons. 
Figure 5. Phosphorylation of N-CAM polypeptides in G8-1 muscle 
cultures and the effect of tunicamycin. G8-1 myoblasts and myo- 
tubes were grown in the presence of [32P]inorganic phosphate in 
the absence or presence of tunicamycin, the cells solubilized with 
NP-40, and N-CAM-reactive polypeptides isolated. Samples were 
then treated with neuraminidase and separated on polyacrylamide 
gels. Lanes 1-4 show [32p]inorganic  phosphate samples from (lane 1) 
myoblasts or (lane 2) myotubes. Lane 3 shows tunicamycin-treated 
samples from myoblasts or (lane 4) myotubes. Molecular mass 
markers are given in kilodaltons. 
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sis of N-CAM in G8-1 cells 
and effect of phospholipase 
C on release of labeled pro- 
teins.  G8-1 myotube  cells 
were  pulse-labeled  for  20 
min with l~S]meflaionine  and 
chased with unlabeled media for various periods of time. Samples 
were then solubilized with NP-40 and N-CAM-reactive polypep- 
tides isolated. Lane I  shows N-CAM polypeptides after a 20-min 
pulse and lanes 2-4 after 10 (lane 2), 30 (lane 3), and 45 min (lane 
4) of chase. Lane 5 shows the effect of phospholipase C on release 
of N-CAM proteins from myotubes. G8-1 cells were labeled with 
[35S]methionine and the culture treated with phospholipase C for 
1 h at 37~  The supernatant was collected, N-CAM polypeptides 
immunoisolated, and samples were neuraminidase treated. Molec- 
ular mass markers are given in kilodaltons. 
ylated N-CAM isoform also appears to be down regulated 
with fusion, as only very low levels are found in myotubes 
(Fig. 5, lane 2). Tunicamycin treatment (Fig. 5, lanes 3 and 
4) of 32p-labeled cultures showed that the phosphoprotein 
band of 145 kD in myoblasts shifts down in molecular mass 
to 120-125 kD, suggesting that the label is incorporated on 
amino acids rather than carbohydrate. As this  120-125-kD 
phosphorylated band is only found in myoblasts and is not 
present in myotubes, the major desialo N-CAM transcript in 
myoblasts is probably a transmembrane isoform that can be 
phosphorylated and is  down regulated with  fusion.  It is, 
however, not possible to n~e out that this apparent down 
regulation could also be a consequence of differential phos- 
phorylation. The presence of a transmembrane N-CAM iso- 
form in myoblasts is also consistent with other studies that 
show that myoblasts express a 6.7-kb mRNA species (7,  10) 
that contains the coding potential to generate a  transmem- 
brahe isoform (10). In an attempt to further analyze the bio- 
synthesis of N-CAM isoforms pulse-chase experiments were 
carded out.  Cultures of G8-1  myotubes were pulsed with 
[35S]methionine  for 20 min and then chased for up to 90 
min.  Fig.  6  shows the four main N-CAM bands found in 
[35S]methionine-labeled myotubes. After a chase of 30 min 
the bands of 120 and 145 kD appear to decrease in intensity. 
By 45 min these bands have disappeared and the  120-kD 
band appears to be chased into the 125-kD band and the 145- 
kD band is chased into the 155-kD band (Fig. 6). It is likely 
that the major desialo isoforms of myotubes are of 125 and 
155 kD and that the bands of 120 and 145 kD are processing 
intermediates. This result also shows that the myoblast 145 
kD isoform co-migrates with an additional intermediate des- 
tined to become a  155-kD  isoform. Further proof that the 
125- and 155-kD  isoforms are expressed at the cell surface 
came from experiments that showed they could be released 
from the cell surface by phospholipase C. The brain N-CAM 
isoform of 120 kD, but not the 140- or 180-kD isoforms, has 
recently been shown to be nontransmembrane and bound to 
the membrane via linkage through phosphatidylinositol (18). 
G8-1  myoblasts and myotubes in culture were labeled with 
[35S]methionine  and  cells  treated  with  phospholipase  C. 
Released N-CAM was then immunoisolated. Under the con- 
Figure 7. Effect of  phosphatidylinositol-specific  phospholipase C on cell surface N-CAM. Indirect itmnunofluorescence  was used to analyze 
the expression of N-CAM in the absence and presence of the enzyme. (a and c) Phase-contrast views focused to highlight the myotubes 
that  sit  above the  cell  monolayer;  (b  and  d)  the  same ceils  stained with  anti-N-CAM  in  the  absence  (b)  or  presence  (d)  of 
phosphatidylinositol-specific phospholipase C. Bar, 50 Ixm. 
The Journal of Cell Biology,  Volume 105, 1987  1382 ditions of  assay, cells were not detached from the culture dish 
by enzyme treatment. Fig. 6 (lane 5) shows that two N-CAM 
polypeptides of 125 and 115 kD are released from the cell 
membrane by phospholipase C  in myotubes. No N-CAM 
polypeptides were detected in media after similarly labeled 
cells were  incubated in the absence of phospholipase  C. 
These data show that two individual N-CAM isoforms are 
specifically released from the myotube membrane by phos- 
pholipase C with no evidence of bands of 120 and 145 kD, 
suggesting that these intermediates in myotubes are not ex- 
posed at the cell surface, and, as shown above, are likely to 
be cytoplasmic processing intermediates. 
Phosphatidylinositol-specific Phospholipase C 
Specifically Releases N-CAM  from Myotubes 
We showed above that phospholipase C specifically released 
N-CAM bands of 125 and 155 kD from myotube cultures. To 
determine whether this release of N-CAM was specific to 
myotubes, as may be expected from the size of the released 
N-CAM proteins, we carried out an indirect immunofluores- 
cence analysis of myotube cultures for N-CAM in the ab- 
sence and presence of phosphatidylinositol-specific phos- 
pholipase C. Fig. 7, a  and b shows the staining profile of a 
C2 myotube culture reacted with N-CAM antibody and is 
very similar to the profile shown in Fig. 1; both myoblasts 
and myombes are strongly stained. Myotube cultures that 
had  been  treated with phosphatidylinositol-specific phos- 
photipase C gave a dramatically different  result (Fig. 7, c and 
d). Here we found that N-CAM irrmqunoreactivity  was re- 
moved from the myotube membrane while the staining inten- 
sity on myoblasts was little changed. Taken together with the 
results shown above, we conclude that the 125- and 155-kD 
N-CAM isoforms are linked to the membrane via phosphati- 
dylinositol linkage and that this occurs specifically in myo- 
tubes but not in myoblasts. 
Northern Blot Analysis of  N-CAM in G8-1 Cells 
Fig.  8  shows a  Northern blot analysis of poly(A)  + RNA 
from G8-1 cells at four different stages of  development in cul- 
ture probed with the mouse brain N-CAM probe pM1.3 (16). 
G8-1 myoblasts express two N-CAM hybridizing bands only 
of 6.7 and 5.2 kb and at no timepoint did we find only the 
6.7-kb band. It is not until the second time point that the 
2.9-kb band is seen. The level of the 2.9-kb band continues 
to rise through the third and fourth time point and is the ma- 
jor N-CAM mRNA at the fourth time point. Myogenesis in 
G8-1 cells is also accompanied by the down regulation of  hqe 
63-kb band. Thus, myogenesis is accompanied by activation 
of  the 2.9-kb band, a down regulation of  the 6.7-kb band, and 
a relative increase in the 5.2-kb band. There is also a slight 
but reproducible increase in apparent size of the 5.2-kb band 
during myogenesis. Whether this means there is heterogene- 
ity in the 5.2-kb band due to alternative splicing remains to 
be determined. 
To quantitate accurately the relative changes in the various 
N-CAM  mRNA  species,  Northern  blot  autoradiographs 
were scanned after hybridization with the pML3 probe. In 
addition,  the blot  was  stripped  and  rehybridized with  a 
eDNA probe to GPDH (24) (Fig. 8 b). The GPDH mRNA 
does not change during myogenesis (13) and can therefore be 
used as an internal standard to quantitate N-CAM mRNAs. 
CK levels in the cultures were also measured to allow the ki- 
netics of fusion to be followed. Fig. 9 shows the changes in 
various N-CAM mRNAs after normalizing to GPDH levels. 
The broad changes shown in Fig. 7  are reproduced here. 
Myogenesis, as indexed by increases in CK, is accompanied 
by a down regulation of the 6.7-kb band, an up regulation of 
the 2.9-kb band, and an increase in the 5.2-kb band. Interest- 
ingly, the temporal expression of  the 2.9-kb band follows the 
rise in CK, whereas the 5.2-kb band does not. The rise in 
the 5.2-kb band does, however,  parallel the profile of total 
N-CAM protein accumulation in the culture. 
Analysis  of  mRNA from C2 cells gave essentially  the same 
results as those found with the G8-1 cells with respect to the 
molecular size of  mRNAs and their alteration with differenti- 
ation in culture (data not shown). This is in contrast to a 
previous study using total RNA where no hybridizing bands 
were detected in C2 myoblasts (7). 
Figure  8. Northern blot analysis 
of N-CAM mRNA during myo- 
genesis of  G8-1 cells. G8-t cells 
were grown for (lane 1) 2, (lane 
2) 3, (lane 3) 6 , and (lane 4) 
10 d of culture, harvested, and 
mRNA extracted, mRNA sam- 
pies were processed for North- 
em blot analysis and hybridized 
to  the  N-CAM eDNA  probe 
pM1.3. Filters were autoradio- 
graphed at  -70~  in the pres- 
ence of  intensifying  screens. (b) 
The Northern blot from a was 
stripped of hybridized N-CAM 
probe and rehybridized with a 
GPDH probe recognizing  a tran- 
script  of invariant abundance 
during myogenesis  to allow ac- 
curate  relative quantitation of 
total poly  (A)  + RNA per gel 
track. 
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Figure 9. Quantitation  of N-CAM mRNA bands during myogenesis 
of G8-1 cells. Autoradiographs  of Northern blots were scanned on 
a densitometer after probing with N-CAM or GPDH probes. The 
N-CAM hybridizing  bands at 6.7 (triangles), 5.2 (squares), and 2.9 
kb (solid circles) were normalized against the GPDH band. The 
graph is plotted as relative N-CAM levels versus time in culture for 
each of  the mRNA bands. These graphs are compared with CK lev- 
els (open circles) in the same cultures. 
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A  number of studies have now shown N-CAM to be ex- 
pressed by skeletal muscle (6-9,  17, 26, 27, 30, 32, 33, 38, 
43, 44, 46). During muscle development N-CAM is present 
at the cell membrane of growing myofibers, but as develop- 
ment proceeds it is down-regulated and adult myofibers do 
not express N-CAM (8, 26, 28). N-CAM is, however,  still 
concentrated at the neuromuscular  junction in adults (6, 26, 
32).  Several experimental or pathological states can cause 
N-CAM to be expressed at the sarcolemma. For instance, 
denervation or nerve crush cause rapid increases in N-CAM 
transcription in muscle (6, 27, 32), and similar effects are 
found by blocking muscle activity by tetrodotoxin (6)  or 
botulinum toxin (27). Studies on experimental muscle regen- 
eration (Moore, S. E., and E  S. Walsh, unpublished obser- 
vations) or human disease (43) where regeneration is part of 
the pathology, show N-CAM-positive fibers indicating that 
N-CAM expression is a correlate of the program of muscle 
regeneration. 
N-CAM protein expression has now been studied in mus- 
cle cell cultures (7, 8, 26, 30, 46), and one study has reported 
on N-CAM-related mRNA species in culture (7). One of the 
difficulties in comparing the above studies is that different 
cell types, both primary and cell lines, have been used; an- 
other is that different stages of development and different an- 
alytical methods have been used to analyze N-CAM expres- 
sion. The most detailed study (7) has shown that there are 
clear changes in N-CAM polypeptides during myogenesis in 
vitro. Myoblasts predominantly express a  140-kD polypep- 
tide, while myotubes predominantly express a 125-kD poly- 
peptide. Analysis of Northern blots using a mouse N-CAM 
eDNA probe showed that there were three N-CAM-related 
bands of 6.7, 5.2, and 2.9 kb, and of these, the 6.7-kb band 
predominates in myoblasts, while the 5.2- and 2.9-kb bands 
predominate in myotubes, eDNA clones encoding human 
muscle N-CAM have recently been isolated by us (10, 45) and 
additional brain clones have been isolated by others (16, 19, 
28, 29). We identified a eDNA clone that encodes a trans- 
membrane N-CAM isoform and an alternatively spliced ver- 
sion of this that encoded nontransmembrane isoforms. The 
transmembrane isoform is encoded by the 6.7-kb mRNA (10), 
and these data plus the present studies strongly suggest that 
the  145-kD  isoform is  the protein  product  of the  6.7-kb 
mRNA. The 6.7-kb muscle transcript shares extensive se- 
quence homology with the 140-kD brain N-CAM isoform 
and it remains to be determined by what mechanism arises 
the slight increase in size of this isoform versus the brain 
homologue, mRNA species of 5.2 and 4.3 kb in human mus- 
cle and 5.2 and 2.9 kb in G8-1 cells encode nontransmem- 
brane isoforms, and, via alternative splicing (40), these tran- 
scripts contain a  muscle-specific N-CAM sequence of 37 
amino acids in their extracellular region (10). As the 5.2- and 
2.9-kb mRNAs accumulate predominantly in myotubes it 
seems likely that the 125- and 155-kD isoforms are their pro- 
tein products. It is, however,  not yet possible to definitely 
state which mRNA encodes which protein. 
In primary human cell ctfltures we showed (26) that N-CAM 
was present on myoblasts and co-distributed with other myo- 
blast cell surface antigens. Similar conclusions have been 
made from analyses carried out on primary chicken and rat 
muscle cell cultures (8, 17). We show here that mouse muscle 
cell lines behave in a manner similar in most respects to the 
primary cultures. All mononucleate cycling myoblasts were 
found to be N-CAM positive. One of the striking features of 
the expression of N-CAM in primary muscle cultures and 
cell  lines  is  the  increased  intensity  of  staining  in  well 
differentiated cultures. This qualitative impression has been 
quantitated for the first time and we found almost a 4-fold 
increase in N-CAM levels in G8-1 cells and a D-fold increase 
in C2 cells during myogenesis. These two cell lines grow 
differently in culture. G8-1 cells fuse with much slower ki- 
netics and are not fully mature until ~,,12 d  after plating, 
while C2 cells are maximally fused after only 7 d. The pro- 
cess of  activation of N-CAM is, however, the same in the two 
cell lines in that the main rise in N-CAM levels precedes fu- 
sion. This was found by comparing N-CAM with two other 
independent markers of  myogenesis, namely the cytoplasmic 
enzyme CK and cell membrane AchR. The b.cthq and N-CAM 
have a number of properties in common. These include ac- 
cumulation, albeit topographically distinct, at the neuromus- 
cular junction (6, 27, 32) and their coregulation on myofibers 
by innervation status (6, 9, 27). However, they differ in that 
N-CAM is present on cycling myoblasts (8, 17, 26), and we 
show here that the activation of N-CAM during in vitro myo- 
genesis precedes AchR. It is not known which cells are ac- 
cumulating greater amounts of N-CAM before fusion. Some 
possibilities are that either committed myoblasts whose num- 
bers are likely to increase before fusion, or, alternatively, cell 
confluency may play a role such that as the number of cells 
in the culture increased there was an increase in N-CAM lev- 
els per cell. Further work will be required to distinguish be- 
tween these or other possibilities. One additional difference 
between N-CAM and AchR is their ability to be regulated in 
culture  by  certain  exogenously  added  agents  such  as 
tetrodotoxin (22)  and thyroid hormones (35), but we were 
unable to show any changes in N-CAM levels  with these 
agents. 
Western blotting and biosynthesis studies were used to 
study N-CAM  proteins  during  myogenesis.  The  Western 
blots showed an extremely polydisperse pattern for N-CAM, 
and it is not until after neuraminidase treatment that specific 
bands are observed. The banding pattern found after neur- 
aminidase treatment was identical for G8-1 and C2 cells. 
Myoblasts expressed a band of 145 kD and small amounts of 
a 120-kD protein. These stayed effectively constant through- 
out the culture period but bands of 125 and 155 kD appeared. 
In myotube cultures the major band present was  125  kD 
(65 % of  total). Thus, at the protein level muscle development 
in culture is accompanied by the activation of 125- and 155- 
kD isoforms. The major problem with the Western blot anal- 
ysis is that it shows the total cell-associated N-CAM only, 
and does not show which isoforms are expressed at the cell 
surface or whether one band is a precursor of another. To re- 
solve this question, biosynthetic experiments were carried 
out after [32p]inorganic phosphate or [3~S]methionine label- 
ing. The major N-CAM protein present in myoblasts is of 145 
kD and is likely to be transmembrane since it can be phos- 
phorylated and rnyoblasts specifically express a 6~7-kb mRNA 
that encodes a transmembrane isoform (10). This isoform is 
down-regulated with fusion and does not appear in myo- 
tubes. Myotubes express two isoforms of 125 and 155 kD that 
are bound to the plasma membrane via phosphatidylinositol 
linkage and are therefore unlikely to be transmembrane. The 
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labeled samples showed clearly that the 145-kD transmem- 
brane isoform was down-regulated with fusion, yet by West- 
ern analysis and biosynthesis a strong band appeared at 145 kD 
in myotubes.  Pulse-chase experiments allowed us  to con- 
clude that this band in myotubes and an additional band of 
120 kD were precursors of 155- and 125-kD isoforms. It is 
likely that the  145- and  120-kD intermediates are not ex- 
pressed at the cell surface as they could not be released from 
the cell membrane by phospholipase C, whereas the mature 
products were. Thus, myotubes are the first cell type to be 
identified that have two distinct N-CAM isoforms that are 
phosphatidylinositol linked. The only other N-CAM isoform 
to be identified that is phosphatidylinositol linked is the 120- 
kD isoform expressed by glial cells in culture (18). However, 
glial cells also synthesize an N-CAM isoform of 140-kD that 
is transmembrane. We showed that phospholipase C action 
could completely clear the myotube membrane of N-CAM, 
whereas  in glial cells it is likely that the  140-kD  isoform 
would remain. It has been suggested (18) that the linkage of 
N-CAM to the plasma membrane via phosphatidylinositol 
could provide a  mechanism  for rapid release of cell-cell 
bonds. Whether this mechanism plays a role in the formation 
and innervation of skeletal muscle remains to be determined. 
In addition to the changes found in N-CAM levels and pro- 
tein forms, Northern blot analysis  showed changes  in the 
expression of N-CAM  mRNAs.  The results of this  study 
differed in two ways from the results of Covault et al.  (7). 
First,  the earliest time point studied in culture showed the 
presence of 6.7- and 5.2-kb N-CAM hybridizing bands, and, 
second, the 6.7-kb band was totally down-regulated in late 
myotube cultures.  The common feature between the  two 
studies is that a 2.9-kb mRNA species is up-regulated during 
myogenesis. Interestingly, this RNA species is activated with 
the same kinetics as CK,  whereas the total cell-associated 
N-CAM immunoreactivity increases with different kinetics. 
We also found that the 6.7-kb band was completely down- 
regulated  with  fusion,  suggesting  that this  is  a  myoblast- 
specific transcript. 
A detailed picture is now available of N-CAM expression 
in skeletal muscle using a combination of whole animal and 
culture  models,  and  a  variety of biochemical assays.  Al- 
though a number of roles have been suggested for N-CAM's 
participation in muscle functions, such as fusion, synapto- 
genesis, and histogenesis, there is little in the way of compel- 
ling evidence to support these hypotheses. There is no doubt 
that as a result of detailed molecular studies N-CAM seems 
to be an ideal candidate to play an important role in muscle 
because of its location and the qualitative and quantitative 
changes found in its expression. In addition, through alterna- 
tive splicing, we have shown (10) that there are specific se- 
quences  expressed in the  extracellular region of N-CAM 
isoforms found in myotubes identifying one additional mech- 
anism  for generating structural diversity in this molecule. 
However a variety of assay systems will have to be tested and 
more specific antibodies generated before conclusions can be 
made. Initial attempts to verify the proposed role of N-CAM 
in nerve-muscle interactions (33) have not been positive (3) 
and further studies are clearly required. 
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